Factors associated with adjuvant systemic anti-cancer treatment discontinuation for early breast cancer during the COVID-19 pandemic.

Elinor R GatfieldAdam BatainehBara El KurdiMukesh B MukeshSuat W Loo

Published in: European journal of cancer care (2022)

Factors affecting patients' decisions to discontinue SACT for early breast cancer during the Covid-19 pandemic were elucidated, which may help identify patients requiring additional support.

Keyphrases

early breast cancer
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
patient reported outcomes